Essential Tremor
230
50
61
109
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
34 trials with published results (15%)
Research Maturity
109 completed trials (47% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.1%
14 terminated out of 230 trials
88.6%
+2.1% vs benchmark
5%
11 trials in Phase 3/4
31%
34 of 109 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 109 completed trials
Clinical Trials (230)
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
Attention and Eye Movement in Parkinson's Disease
Magnetoencephalography (MEG) Pilot Study
Transcranial Temporal Interference Stimulation (tTIS) To Modulate Essential Tremor
Echo-Focusing in Patients With Treatment-Resistant Neurologic and Psychiatric Indications (EF001)
Deep Brain Stimulation Surgery for Movement Disorders
Experimental Therapeutics in Essential Tremor Using Cerebellar Transcranial Direct Current Stimulation
Effects of Stimulation Patterns of Deep Brain Stimulation
Cerebellar Research in Ultrasound Stimulation
EMBRACE Tremor BiFUS
Cortical-Basal Ganglia Speech Networks
Staged Bilateral Exablate Treatment of Medication Refractory Essential Tremor
Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET)
Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS
Investigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator Recipients
RAD 1601: EDGE Radiosurgery for Intractable Essential Tremor and Tremor-Dominant Parkinson's Disease
Ultrasound Neuromodulation in Essential Tremor
Image-Guided DBS Programming
Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease
LIFUS For Neurological Disorders